97.8分
★★★★★
站内排序·非疗效
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
ALL SOURCES
全部资讯 619
条件筛选 · 已选 2 项 · 共 619 条展开收起
适应症
多发性骨髓瘤中的免疫调节药物与 cereblon E3 连接酶调节剂：30 年研发历程
Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in Multiple Myeloma: 30 Years in the Making.
97.8分
★★★★★
站内排序·非疗效
炎症性骨髓微环境损害 daratumumab-lenalidomide 在多发性骨髓瘤中的治疗效果
Inflammatory bone marrow microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma.
97.0分
★★★★★
站内排序·非疗效
复发/难治性多发性骨髓瘤中 CAR-T 细胞治疗与双特异性抗体作为单一模式与序贯策略的结局
Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma.
97.0分
★★★★★
站内排序·非疗效
mezigdomide 降解 Ikaros 减轻 T 细胞功能障碍并提高抗骨髓瘤 T 细胞疗法疗效
Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies.
95.9分
★★★★★
站内排序·非疗效
免疫球蛋白恒定结构域作为基于 T 细胞受体的多发性骨髓瘤治疗靶点
Immunoglobulin constant domains as targets for T-cell receptor-based treatment of multiple myeloma.
95.5分
★★★★★
站内排序·非疗效
我如何预防接受双特异性抗体治疗的晚期 B 细胞恶性肿瘤成人患者的感染
How I prevent infections in adults receiving bispecific antibody therapies for advanced B-cell malignancies.
95.1分
★★★★★
站内排序·非疗效
通过整合优化的 CAR 内结构域和 iNKT 衔接器增强 iNKT 细胞免疫治疗
Enhancing iNKT cell immunotherapy through the integration of optimized CAR endodomains and iNKT engagers.
94.0分
★★★★★
站内排序·非疗效
高危冒烟型多发性骨髓瘤：早期治疗与观察之间争议的综述
High-Risk Smoldering Multiple Myeloma: A Review of Controversies in Early Treatment Versus Observation.
92.5分
★★★★★
站内排序·非疗效
MRD 动态预测多发性骨髓瘤进展并揭示免疫治疗干预的脆弱状态
MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma.
91.8分
★★★★★
站内排序·非疗效